05-15-2019 02:13 PM CET - Health & Medicine
Print

Global Protein Therapeutics Market is Expected to thrive at a CAGR of 6.5% during the projected period by 2023|Top Key Players - Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd

Press release from: KD Market Insights



A Comprehensive research study conducted by KD Market Insights on "Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023" report offers extensive and highly detailed historical, current and future market trends in the global and regional/market. The Global Protein Therapeutics market report includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments.

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to reach $217,591 million by 2023, registering a CAGR of 6.5% from 2017 to 2023.

Request for Sample@ www.kdmarketinsights.com/sample/5099

In principle, protein therapy is similar to gene therapy, and involves protein delivery in specific amounts to the body to aid in precise functioning of different glands and other organs in the body. Protein therapeutics play a pivotal role in treatment of an array of different diseases such as diabetes, lymphoma, hepatitis, and others.
Surge in prevalence of chronic diseases and rise in development of plasma-derived therapies supplement the market growth. However, stringent government regulations towards protein therapeutics and high treatment costs per patient impede the market growth. Conversely, increase in novel indications for known protein therapeutics and untapped emerging markets offer lucrative opportunities for the market players.

The protein therapeutics market is segmented based product, application, and geography. By product, the market is divided into monoclonal antibodies, insulin, fusion protein, erythropoietin, interferon, human growth hormone, and follicle stimulating hormone. On the basis of application, it is classified into metabolic disorders, immunologic disorders, hematological disorders, cancer, hormonal disorders, genetic disorders, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The report provides extensive competitive analysis and profiles of key market players, such as Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Pfizer Inc., and Sanofi. Other players (profiles not included in the report) in the value chain analysis include, Biogen, Inc., CSL Behring, and Genentech, Inc.

KEY MARKET BENEFITS
– The study provides an in-depth analysis of the global protein therapeutics market along with the current trends and future estimations to elucidate the imminent investment pockets.
– The report presents quantitative analysis of the market from 2017 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
– Extensive analysis of the market based on application assists in understanding the trends in the industry.
– Key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS

By Product
– Monoclonal Antibodies
– Insulin
– Fusion Protein
– Erythropoietin
– Interferon
– Human Growth Hormone
– Follicle Stimulating Hormone

By Application
– Metabolic Disorders
– Immunologic Disorders
– Hematological Disorders
– Cancer
– Hormonal Disorders
– Genetic Disorders
– Others

By Geography
– North America
– – U.S.
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – UK
– – Italy
– – Spain
– – Rest of Europe
– Asia-Pacific
– – Japan
– – China
– – Australia
– – India
– – South Korea
– – Taiwan
– – Rest of Asia-Pacific
– LAMEA
– – Brazil
– – Saudi Arabia
– – South Africa
– – Rest of LAMEA

Browse Full Report With TOC@ www.kdmarketinsights.com/product/protein-therapeutics-market

Table of Contents:

CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCE ANALYSIS
3.4. GOVERNMENT REGULATIONS
3.5. TOP PLAYER POSITIONING

3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Rise in healthcare expenditure
3.6.1.2. Increase in R&D investments
3.6.1.3. Growth in proteomics research
3.6.1.4. Rise in incidence of chronic diseases

3.6.2. Restraints
3.6.2.1. High production costs
3.6.3. Opportunities
3.6.3.1. Training for professionals
3.6.3.2. Greater potency with reduced costs and increasing affordability
3.6.3.3. Untapped emerging markets

CHAPTER 4 PROTEIN THERAPEUTICS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. MONOCLONAL ANTIBODY
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. INSULIN
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. FUSION PROTEIN
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. ERYTHROPOIETIN
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

4.6. INTERFERON
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast

4.7. HUMAN GROWTH HORMONE
4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
4.8. FOLLICLE-STIMULATING HORMONE
4.8.1. Key market trends
4.8.2. Key growth factors and opportunities
4.8.3. Market size and forecast

CHAPTER 5 PROTEIN THERAPEUTICS MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. METABOLIC DISORDERS
5.2.1. Market size and forecast
5.3. IMMUNOLOGICAL DISORDERS
5.3.1. Market size and forecast
5.4. HEMATOLOGICAL DISORDERS
5.4.1. Market size and forecast
5.5. CANCER
5.5.1. Market size and forecast
5.6. HORMONAL DISORDERS
5.6.1. Market size and forecast
5.7. GENETIC DISORDERS
5.7.1. Market size and forecast
5.8. OTHERS
5.8.1. Market size and forecast

CHAPTER 6 PROTEIN THERAPEUTICS MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.1.1. Market size and forecast, by country
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast, by country
6.2.4. Market size and forecast, by product
6.2.5. Market size and forecast, by application
6.2.5.1. U.S. market size and forecast, by product
6.2.5.2. U.S. market size and forecast, by application
6.2.5.3. Canada market size and forecast, by product
6.2.5.4. Canada market size and forecast, by application
6.2.5.5. Mexico market size and forecast, by product
6.2.5.6. Mexico market size and forecast, by application
Continue@.....

Check For Discount@ www.kdmarketinsights.com/discount/5099

About Us:

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
Telephone: +1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
Follow us - Facebook, Twitter, Linked In

This release was published on openPR.
News-ID: 1740526 • Views: 190
More releasesMore releases

You can edit or delete your press release here: